• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

14/02/2025 17:49

Omkar Pharmachem - Board Meeting Outcome for The Board Meeting Held On 14Th February 2025 For Approval Of Unaudited Financial

Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 14th February, 2025 has considered and approved the unaudited Financial Results of the Companyand Limited Review Report for the Quarter ended on 31.12.2024.